Cargando…
Pharmacological Inhibition of S100A4 Attenuates Fibroblast Activation and Renal Fibrosis
The TGF-β/Smad3 signaling pathway is an important process in the pathogenesis of kidney fibrosis. However, the molecular mechanisms are not completely elucidated. The current study examined the functional role of S100A4 in regulating TGF-β/Smad3 signaling in fibroblast activation and kidney fibrosis...
Autores principales: | Wen, Jia, Jiao, Baihai, Tran, Melanie, Wang, Yanlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455228/ https://www.ncbi.nlm.nih.gov/pubmed/36078170 http://dx.doi.org/10.3390/cells11172762 |
Ejemplares similares
-
Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis
por: Jiao, Baihai, et al.
Publicado: (2021) -
STAT6 Deficiency Attenuates Myeloid Fibroblast Activation and Macrophage Polarization in Experimental Folic Acid Nephropathy
por: Jiao, Baihai, et al.
Publicado: (2021) -
Pharmacological Inhibition of STING/TBK1 Signaling Attenuates Myeloid Fibroblast Activation and Macrophage to Myofibroblast Transition in Renal Fibrosis
por: Zeng, Haimei, et al.
Publicado: (2022) -
Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis
por: Xiong, Chongxiang, et al.
Publicado: (2016) -
Role of Bone Marrow-Derived Fibroblasts in Renal Fibrosis
por: Yan, Jingyin, et al.
Publicado: (2016)